Monday, October 26, 2026 · Daily editionET --:--:--

Not recruiting yet

Modulating Locomotor-Respiratory Coupling Through Adaptive Exoskeleton Assistance in Patients With COPD

NCT07703527 · University of Nebraska · Updated 14 July 2026

What is being tested
Hip Exoskeleton-Assisted Walking
For
COPD (Chronic Obstructive Pulmonary Disease)
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 45 years to 75 years. About 10 people. The full rules are on the registry page.
Where
United States
When
Starts or started Sept 2026, ends Sept 2028. Registered 14 July 2026.
Results
None posted yet.

In the researchers' words

1\) Purpose: To improve pulmonary rehabilitation outcomes for individuals with COPD by evaluating the effectiveness of a hip-assisted exoskeleton during a single pulmonary rehabilitation session. 2) Eligibility criteria: Participants must be between 45-75 years old, any gender, but must have a BMI of less than 35 kg/m\^2, free from co-morbidities that may affect walking patterns, and must have moderate to severe COPD with no other pulmonary or cardiac issues. (Eligible participants will undergo a screening process which includes 6-minute walking test, medical history exam, and spirometry evaluation.) 3) Intervention and evaluation: The experimental collection will be conducted at the Biomechanics Research Building at the University of Nebraska at Omaha. Participants are required to participate in two sessions on two separate days, both including a 30-minute walking session with one session wearing the hip exoskeleton and the other session without the device.
ClinicalTrials.gov, NCT07703527

Sites

  • UNO BiomechanicsOmaha, Nebraska, United States